By expenditures
| Name | Title | Type |
|---|---|---|
| Emily Lin | Associate Vice President For Finance | Auditee |
| Patrick Dull | TREASURY ACCOUNTANT | Auditee |
| Ryan Engelstad | PARTNER | Auditee |
| Rebekah Martin | Principal | Auditee |
| No contacts on file | ||
| ID | Year | Date Accepted | Auditor | Spend |
|---|---|---|---|---|
| 375827 | 2025 | 2025-12-18 | BAKER TILLY US LLP | $41.09M |
| 333902 | 2024 | 2024-12-19 | Baker Tilly US LLP | $38.89M |
| 289357 | 2023 | 2024-02-07 | Baker Tilly US LLP | $38.46M |
| 38874 | 2022 | 2022-12-12 | Baker Tilly US LLP | $43.68M |
| Audit | Year | Accepted | Finding | Ref | Severity | Repeat | Requirement |
|---|---|---|---|---|---|---|---|
| 375827 | 2025 | 2025-12-18 | 1165293 | 2025-003 | Material Weakness | Yes | N |
| 375827 | 2025 | 2025-12-18 | 1165292 | 2025-003 | Material Weakness | Yes | N |
| 375827 | 2025 | 2025-12-18 | 1165291 | 2025-003 | Material Weakness | Yes | N |
| 375827 | 2025 | 2025-12-18 | 1165290 | 2025-003 | Material Weakness | Yes | N |
| 375827 | 2025 | 2025-12-18 | 1165289 | 2025-003 | Material Weakness | Yes | N |
| 375827 | 2025 | 2025-12-18 | 1165288 | 2025-002 | Material Weakness | Yes | N |
| 375827 | 2025 | 2025-12-18 | 1165287 | 2025-002 | Material Weakness | Yes | N |
| 375827 | 2025 | 2025-12-18 | 1165286 | 2025-002 | Material Weakness | Yes | N |
| 375827 | 2025 | 2025-12-18 | 1165285 | 2025-002 | Material Weakness | Yes | N |
| 375827 | 2025 | 2025-12-18 | 1165284 | 2025-002 | Material Weakness | Yes | N |
| 375827 | 2025 | 2025-12-18 | 1165283 | 2025-001 | Material Weakness | Yes | N |
| 375827 | 2025 | 2025-12-18 | 1165282 | 2025-001 | Material Weakness | Yes | N |
| 375827 | 2025 | 2025-12-18 | 1165281 | 2025-001 | Material Weakness | Yes | N |
| 375827 | 2025 | 2025-12-18 | 1165280 | 2025-001 | Material Weakness | Yes | N |
| 375827 | 2025 | 2025-12-18 | 1165279 | 2025-001 | Material Weakness | Yes | N |
| 333902 | 2024 | 2024-12-19 | 1092529 | 2024-001 | Significant Deficiency | - | N |
| 333902 | 2024 | 2024-12-19 | 1092528 | 2024-001 | Significant Deficiency | - | N |
| 333902 | 2024 | 2024-12-19 | 1092527 | 2024-001 | Significant Deficiency | - | N |
| 333902 | 2024 | 2024-12-19 | 1092526 | 2024-001 | Significant Deficiency | - | N |
| 333902 | 2024 | 2024-12-19 | 1092525 | 2024-001 | Significant Deficiency | - | N |
| 333902 | 2024 | 2024-12-19 | 516087 | 2024-001 | Significant Deficiency | - | N |
| 333902 | 2024 | 2024-12-19 | 516086 | 2024-001 | Significant Deficiency | - | N |
| 333902 | 2024 | 2024-12-19 | 516085 | 2024-001 | Significant Deficiency | - | N |
| 333902 | 2024 | 2024-12-19 | 516084 | 2024-001 | Significant Deficiency | - | N |
| 333902 | 2024 | 2024-12-19 | 516083 | 2024-001 | Significant Deficiency | - | N |
| 289357 | 2023 | 2024-02-07 | 942963 | 2023-001 | - | Yes | N |
| 289357 | 2023 | 2024-02-07 | 366521 | 2023-001 | - | Yes | N |
| 38874 | 2022 | 2022-12-12 | 618058 | 2022-002 | - | - | L |
| 38874 | 2022 | 2022-12-12 | 618057 | 2022-004 | - | - | N |
| 38874 | 2022 | 2022-12-12 | 618056 | 2022-003 | - | - | N |
| 38874 | 2022 | 2022-12-12 | 618055 | 2022-001 | Significant Deficiency | - | N |
| 38874 | 2022 | 2022-12-12 | 618054 | 2022-001 | Significant Deficiency | - | N |
| 38874 | 2022 | 2022-12-12 | 41616 | 2022-002 | - | - | L |
| 38874 | 2022 | 2022-12-12 | 41615 | 2022-004 | - | - | N |
| 38874 | 2022 | 2022-12-12 | 41614 | 2022-003 | - | - | N |
| 38874 | 2022 | 2022-12-12 | 41613 | 2022-001 | Significant Deficiency | - | N |
| 38874 | 2022 | 2022-12-12 | 41612 | 2022-001 | Significant Deficiency | - | N |